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How type I skeletal muscle inherently maintains high
oxidative and vascular capacity in the absence of
exercise is unclear. We show that nuclear receptor
ERRg is highly expressed in type I muscle and,
when transgenically expressed in anaerobic type II
muscles (ERRGO mice), dually induces metabolic
and vascular transformation in the absence of exer-
cise. ERRGO mice show increased expression of
genes promoting fat metabolism, mitochondrial
respiration, and type I fiber specification. Muscles
in ERRGO mice also display an activated angiogenic
programmarked by myofibrillar induction and secre-
tion of proangiogenic factors, neovascularization,
and a 100% increase in running endurance. Surpris-
ingly, the induction of type I muscle properties by
ERRg does not involve PGC-1a. Instead, ERRg
genetically activates the energy sensor AMPK in
mediating the metabovascular changes in ERRGO
mice. Therefore, ERRg represents a previously
unrecognized determinant that specifies intrinsic
vascular and oxidativemetabolic features that distin-
guish type I from type II muscle.
INTRODUCTION
Tissue vascular supply is tightly coupled to its oxidative capacity.
This is especially evident in skeletal muscle beds enriched in
either oxidative slow-twitch or glycolytic fast-twitch myofibers
(Flu¨ck and Hoppeler, 2003; Pette and Staron, 2000). Slow-twitch
muscles are characterized by high mitochondrial content,
fatigue-resistant (type I) fibers, and dense vascularity to ensure
a steady and prolonged supply of oxygen and nutrients (Annex
et al., 1998; Cherwek et al., 2000; Ripoll et al., 1979). Fast-twitch
(type II) muscles generally have lower oxidative capacity and
a reduced blood supply and are fatigue sensitive. How the
type I versus the type II muscle vasculature is specified to match
oxidative capacity is unclear.
Previous studies have established that nuclear receptors such
as PPARa, PPARd, and ERRa, along with coregulators PGC-1a,
PGC-1b, and Rip140 control diverse aspects of aerobic respira-Cetion, including fatty acid oxidation, oxidative phosphorylation,
and mitochondrial biogenesis, in skeletal muscle (Arany et al.,
2007; Huss et al., 2004; Lin et al., 2002; Minnich et al., 2001;
Muoio et al., 2002; Seth et al., 2007; Wang et al., 2004). While
signaling factors such as TGF-b1, platelet-derived growth factor,
fibroblast growth factors (FGF) 1 and 2, and vascular endothelial
growth factor (VEGF) are known to stimulate angiogenesis (Car-
meliet, 2000; Ferrara and Kerbel, 2005; Gustafsson and Kraus,
2001), whether and how these factors orchestrate dense vascu-
larization of aerobic muscles is unclear. One possibility is
vascular arborization by coactivator PGC-1a that is induced by
hypoxia and exercise (Arany et al., 2008). However, PGC-1a
knockout mice are viable, still retain oxidative muscle, and
have normal vasculature (Arany et al., 2008; Lin et al., 2004).
Since the intrinsic enrichment of blood flow to aerobic muscles
in the absence of exercise is unlikely to depend on PGC-1a
induction, we speculate the existence of an alternative regulatory
angiogenic pathway.
Estrogen receptor-related receptor g (ERRg), like other
members of the ERR subfamily, is a constitutively active orphan
nuclear receptor, though unlike ERRa and b, it is more selectively
expressed inmetabolically active and highly vascularized tissues
such as heart, kidney, brain, and skeletal muscles (Gigue`re,
2008; Heard et al., 2000; Hong et al., 1999). In vitro studies
suggest that ERRg activates genes such as Pdk4 and Acadm
that play a regulatory role in oxidative fat metabolism (Huss
et al., 2002; Zhang et al., 2006). Furthermore, a comprehensive
gene expression analysis identified ERRg as a key regulator of
multiple genes linked to both fatty acid oxidation and mitochon-
drial biogenesis in cardiac muscles (Alaynick et al., 2007; Dufour
et al., 2007). Expression of ERRg is also induced in variety of
tumorswith hypermetabolic demands and abundant vasculature
(Ariazi et al., 2002; Cheung et al., 2005; Gao et al., 2006). There-
fore, we explored the potential of ERRg in controlling the intrinsic
angiogenic pathway in oxidative slow-twitch muscles. We found
ERRg to be exclusively and abundantly expressed in oxidative
(type I) slow-twitch muscles. Transgenic expression of ERRg in
fast-twitch type II muscle triggers aerobic transformation, mito-
chondrial biogenesis, VEGF induction, and robust myofibrillar
vascularization, all in the absence of exercise. These intrinsic
effects of ERRg do not depend on PGC-1a induction, but rather
are linked to activation of the metabolic sensor AMPK. These
findings reveal an exercise-independent ERRg pathway that
promotes and coordinates vascular supply and metabolic
demand in oxidative slow-twitch muscles.ll Metabolism 13, 283–293, March 2, 2011 ª2011 Elsevier Inc. 283
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Figure 1. Skeletal Muscle ERRg Expression
(A) ERRg gene (lower panel) and/or protein (upper
panel) expression in quadriceps (QUADS), white
gastrocnemius (WG), red gastrocnemius (RG),
and soleus (SOL) isolated from C57BL/6J mice
(n = 4).
(B) Representative images of b-galactosidase-
stained muscles.
(C) Expression of transgene transcript (lower
panel) and protein (upper panel) in quadriceps of
WT and TG founders 425 and 421.
(D) Representative hindlimbs from WT and trans-
genic mice.
(E) Dissected hindlimb muscle beds (adductor
[ADDT], quadriceps, gastrocnemius [GASTROC],
and soleus). In (A) and (C), data are presented as
mean ± SD (n = 4). See Figure S1.
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Skeletal Muscle ERRg Expression
Because skeletal muscle is a functionally heterogeneous tissue
consisting of both aerobic slow-twitch and glycolytic fast-twitch
muscles, we re-evaluated ERRg expression in the context of
different myofibrillar beds. We found that ERRg transcript is
highly expressed in oxidative muscles such as soleus and red
gastrocnemius, with minimal expression in glycolytic quadriceps
and white gastrocnemius (Figure 1A, lower panel). ERRg protein
is undetectable in quadriceps but highly expressed in soleus
(Figure 1A, upper panel).
Previously, we described viable ERRg +/ mice in which a
b-galactosidase protein-coding region without the promoter
was introduced in-frame with the initiation site of the Esrrg
gene (Alaynick et al., 2007) such that the enzyme mimics the
expression of endogenous ERRg. b-galactosidase staining of
different muscle beds from ERRg +/ adult mice further
confirmed that the receptor is highly expressed in oxidative
(e.g., soleus and red gastrocnemius) compared to the minimal
levels in glycolytic muscles (e.g., quadriceps and white gastroc-
nemius) (Figure 1B).284 Cell Metabolism 13, 283–293, March 2, 2011 ª2011 Elsevier Inc.Transgenic Muscle-Specific ERRg
Overexpression
The above expression pattern of ERRg
supports its presumptive role in oxidative
and slow-twitch muscle biology. To test
this idea, we generated transgenic mice
selectively expressing ERRg in skeletal
muscles under the control of the human
a-skeletal actin promoter (Muscat and
Kedes, 1987; Wang et al., 2004). Two
ERRg-overexpressing (ERRGO) trans-
genic lines were obtained (TG 421 and
425) showing both transcript (lower
panel) and protein (upper panel) in fast-
twitch quadriceps (Figure 1C). Gross
anatomical analysis of hindlimb muscles
(Figure 1D) and dissection of individual
muscle beds (Figure 1E) revealed
enhanced red coloration (characteristicof oxidative fibers) in transgenic compared to WT muscle.
Importantly, slow-twitch (soleus) muscle, already high in ERRg
expression, was not affected (Figure 1E), presumably because
it is already fully oxidative. In addition, oxidative biomarkers
myoglobin and cytochrome c were induced in the quadriceps
of both the transgenic lines compared to WT mice (Figure S1).
For subsequent studies we focused on TG 421, due to slightly
higher biomarker expression in this progeny.
Fast- to Slow-Twitch Transformation of Skeletal Muscle
by ERRg
To study the transcriptional effect of ERRg, muscle gene expres-
sion was measured in quadriceps from WT and ERRGO mice. In
gene array analysis, we found that ERRg regulated a total of 1123
genes in skeletal muscles, of which 623 genes were induced.
Gene ontology-based classification of these genes is presented
in Figure 2A. The majority of the upregulated genes belong to
either mitochondrial biology (90) or oxidative metabolism (43),
encoding various components of the fatty acid oxidation
pathway as well as the oxidative respiratory chain, reflective of
aerobic adaptation (described in Table S1). Furthermore, con-
tractile genes, especially ones associated with slow myofibers,
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Figure 2. ERRg Promotes Oxidative Muscle
Transformation
(A) Gene ontology classification of positively regu-
lated genes. Gene selection was based on p < 0.05
on Bonferroni’s multiple comparison test for fold
change (n = 3).
(B) ERRg increases expression of oxidative
metabolism (Ucp3, Pdk4, Cycs, Cox5a, Lpl) and
oxidative muscle (Mhc1a, Mhc2a) but not glyco-
lytic muscle (Mhc2b) biomarker genes. Data are
presented as mean ± SD from n = 6 samples.
(C) ERRg increases protein expression of myo-
globin, cytochrome c, and uncoupling protein 3
(n = 3).
(D) Representative images of SDH-stainedWT and
transgenic gastrocnemius cryosections. Similar
results were obtained from n = 4 mice.
(E) OCAR/ECAR ratio representing a shift in cellular
energy production to oxidative phosphorylation.
Data is presented as mean ± SD. * represents
statistically significant difference between WT and
transgenicmice or betweenWT and ERRg-overex-
pressing C2C12 cells (p < 0.05, unpaired Student’s
t test). See Figure S2 and Tables S1, S2, and S4.
Cell Metabolism
ERRg Increases Muscle Vascularizationwere also activated, raising the possibility of fast-to-slow trans-
formation linked to the metabolic switch (Table S2).
We confirmed that key biomarker genes associated with
oxidative metabolism (Ucp3, Pdk4,Cycs,Cox5a, Lpl) and oxida-
tive myofibers (Mhc Ia, Mhc IIa) but not glycolytic myofibers
(Mhc IIb) were induced by ERRg in quadriceps of transgenic
mice (Figure 2B). Conversely, many of the biomarker genes
tested (Ucp3, Cycs, Acscl1, Cox6a2, Ppara) were found to be
downregulated by siRNA-mediated ERRg knockdown in
primary cultured myotubes (Figure S2A) isolated from oxidative
muscles (soleus and red gastrocnemius). Moreover, the oxida-
tive changes were confirmed at the protein level, as exemplified
by increased expression of myoglobin, cytochrome c, and UCP3
in transgenic relative to WT muscle (Figure 2C). Furthermore,
staining of gastrocnemius cryosections for defining oxidative
mitochondrial enzyme SDH activity revealed an increase in
oxidative myofibers in ERRGO compared to WT mice (Fig-
ure 2D), which was confirmed by electron microscopy (data
not shown).Cell Metabolism 13, 283–2To access the metabolic effects of
ERRg at the cellular level, we measured
the mitochondrial bioenergetics in WT
and ERRg-overexpressing C2C12 cells
using an extracellular flux analyzer.
Specifically, we determined the oxygen
consumption rate (OCR) (an indicator of
mitochondrial respiration) along with the
extracellular acidification rate (ECAR) (a
measure of glycolysis) in these cells
(Figures S2B and S2C). ERRg expression
significantly induced mitochondrial respi-
ration (OCR) and reduced cellular glycol-
ysis (ECAR), resulting in an 85% shift in
thecellular energyproduction ratio toward
oxidative phosphorylation (Figure 2E).The above observations show that ERRg promotes an overt
conversion of glycolytic fast-twitch muscles such as quadriceps
to an oxidative slow-twitch phenotype.
ERRg Promotes Skeletal Muscle Vascularization
Intrinsic vascularization of slow-twitchmyofibers enables abase-
line of exercise-independent fatigue resistance. We speculated
that ERRg, by virtue of its restricted expression to type I fibers,
could, in addition to promoting oxidative metabolism, simulta-
neously induce vessel formation to match the increased oxida-
tive demand. To test this, we first stained muscle cryosections
for PECAM 1 (CD31), an endothelial cell marker that is routinely
used to detect angiogenesis and changes in tissue vasculature.
We found that transgenic muscles showed increased PECAM 1
(Figure 3A) staining compared to WT. Similarly, transgenic
muscle cryosections showed an increase in alkaline phospha-
tase staining, an alternative marker for tissue endothelium (Fig-
ure 3B). These findings point toward a possible induction of
angiogenesis and muscle vascularization by ERRg. To test93, March 2, 2011 ª2011 Elsevier Inc. 285
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Figure 3. ERRg Increases Muscle Vascularization
(A) Increased PECAM 1 staining in transgenic compared to WT gastrocnemius.
(B) Increased alkaline phosphatase staining in transgenic compared to WT tibialis muscles.
(C) Confocal images of microsphere perfused WT and transgenic gastrocnemius. Similar results were obtained from n = 4 experiments in (A)–(C).
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Figure 4. Paracrine Stimulation of Angiogenesis by
ERRg
(A) Tube formation in SVEC4-10 cells treated for 7–8 hr
with conditioned media from WT and ERRg-overexpress-
ing C2C12 myotubes. Similar results were obtained from
4–6 experiments.
(B–D) Expression of Vegfa isoforms in WT and ERRg-over-
expressing C2C12 myotubes (n = 6).
(E) Vegfa concentrations (pg/ml) in conditionedmedia from
2 day differentiated WT and ERRg-overexpressing C2C12
myotubes (n = 3). Data in (B)–(E) are presented as mean ±
SD. * represents significant difference between WT and
ERRg-overexpressing C2C12 cells (p < 0.05, unpaired
Student’s t test). See Figure S3 and Table S3.
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ERRg Increases Muscle Vascularizationwhether ERRg supports formation of functional nonleaky blood
vessels, we used microangiography following intraventricular
perfusion of a fluorescent microspheres (0.1 mM). The imperme-
ability of the microspheres allows their vascular retention,
enabling confocal angiographic ‘‘vascular mapping’’ of intact
and mature blood vessels. Examination of perfused micro-
spheres in WT and transgenic gastrocnemius revealed an
increase in muscle vascularity by ERRg (Figure 3C), showing
that ERRg dually promotes oxidative fiber specification and
neovascularization.
Paracrine Regulation of Muscle Vascularization of ERRg
How might ERRg expressed in myofibers regulate proximal
vascular development? Gene expression studies (Figure 2A
and Table S3) revealed increased expression of 25 angiogenic
genes, including vascular endothelial growth factor A (Vegfa),
in ERRGO quadriceps. Real-time PCR confirmed induction of
two Vegfa isoforms (165 and 189) along with Vegfb and Fgf1 in
transgenic muscles (Figures 3D–3H). Moreover, ERRg as well
as ERRa and ERRb increased the transcription of a Vegfa
promoter-driven luciferase reporter in AD 293 cells (Figure S3).
In addition, we confirmed that the protein levels of Vegfa and
Fgf1 were increased in the quadriceps of the transgenic mice
(Figure 3H), raising the specter that muscle ERRg activates para-
crine networks that are released into the microenvironment to
promote neovascularization.
To directly test whether ERRg triggers paracrine angiogen-
esis, we employed an SVEC4-10 (murine endothelial cells) tube
formation assay. We reasoned that conditioned media from
ERRg-overexpressing muscle cells would contain the appro-
priate signals to induce tube formation in endothelial cells.
Indeed, treatment of SVEC4-10 cells with conditioned media
from ERRg-overexpressing C2C12 myotubes stimulated tube
formation in 7–8 hr (Figure 4A). To confirm that the conditioned
media contains angiogenic signals, we examined the gene
expression in cells and protein levels in the media (by ELISA) of(D–H) Expression of Vegfa-121, Vegfa-165, Vegfa-189, Vegfb, and Fgf1 transcript
n = 6 samples.
(I) ERRg increases VEGFa and FGF1 protein expression (n = 4). * represents signifi
t test).
Cea representative angiokine, Vegfa. We found that overexpression
of ERRg in C2C12myotubes increases expression of Vegfa-121,
-165, and -189 genes (Figures 4B–4D) and increases total Vegfa
secretion (by 4-fold) in the media (Figure 4E). These results
demonstrate that ERRg can induce angiogenic factors such as
myocellular Vegfa to increase angiogenesis in a paracrine
fashion.
Physiological Effects of ERRg-Remodeled Muscle
Aerobic exercise-induced remodeling of skeletal muscles
depends on both an increase in oxidative capacity and new
blood vessel formation, changes that are a critical part of the
physiologic adaptation to training (Bloor, 2005; Egginton, 2009;
Gavin et al., 2007; Gustafsson and Kraus, 2001; Jensen et al.,
2004; Waters et al., 2004). Therefore, we investigated the
potential of ERRg to promote physiological remodeling. First,
in metabolic cage oxymetric studies, we found that the trans-
genic mice exhibited an increase in oxygen consumption (during
both the light and dark cycles) in concert with the observed
increased oxidative metabolism and blood supply to skeletal
muscles (Figure 5A). Second, the ERGGO mice have a lower
respiratory exchange ratio (RER) compared to the WT mice,
indicative of a tendency to preferentially oxidize fat over carbo-
hydrate in the transgenic skeletal muscles (Figure 5B). The
ambulatory activities of WT and transgenic mice were compa-
rable and therefore unlikely to contribute to changes in oxymetric
parameters (Figure S4A). These combined changes led us to
explore whether ERRGO mice acquired enhanced running
endurance. ERRg transgenic mice were able to run longer and
further compared to the WT littermates (Figure 5C). Finally, the
ERRGO mice were subjected to a high-fat/high-carbohydrate
diet to establish whether the induction of endurance muscle
and oxidative RER affected global metabolic balance. As ex-
pected, ERRGO mice gained 35% less weight than WT controls
on a high-fat diet (Figure S4B). These findings demonstrate that
targeting of ERRg increases oxidative metabolism and bloodlevels inWT and transgenic quadriceps. Data are presented asmean ± SD from
cant difference betweenWT and transgenic mice (p < 0.05, unpaired Student’s
ll Metabolism 13, 283–293, March 2, 2011 ª2011 Elsevier Inc. 287
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Figure 5. Physiological Effect of ERRg Overexpression
(A and B) Average oxygen consumption (n = 6–7) (A) and average RER (n = 6–7)
(B) during the light and the dark cycle over a period of 24 hr in WT and trans-
genic mice.
(C) Running endurance as a function of time and distance (n = 6). Data are pre-
sented asmean ± SEM in (A) and (B) and asmean ± SD in (C). * indicates statis-
tically significant difference between the two groups (p < 0.05, unpaired
Student’s t test). See Figure S4.
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ERRg Increases Muscle Vascularizationsupply to skeletal muscle, leading to increased oxygen
consumption, better endurance, and resistance to weight gain.
PGC-1a-Independent Regulation of Aerobic Muscle
by ERRg
PGC-1a is induced by hypoxia and exercise to promote HIF1a-
independent vascularization of type II muscle (Arany et al.,
2008) and further activated by posttranslational modifications
such as deacetylation (Ja¨ger et al., 2007; Puigserver et al.,
2001; Rodgers et al., 2005). Therefore, we asked whether the
ERRg-induced changes in the muscle were due to the induction
and/or activation of PGC-1a. The levels of PGC-1a mRNA,
protein, and acetylation remained unchanged in the ERRg-trans-
formed skeletal muscle (Figures 6A andS5A). Interestingly, of the
two additional ERR isoforms that canmediate PGC-1a signaling,288 Cell Metabolism 13, 283–293, March 2, 2011 ª2011 Elsevier Inc.ERRb, but not ERRa, was also significantly induced in transgenic
muscle (Figure 6A) (Mootha et al., 2004; Schreiber et al., 2003;
Huss et al., 2002).
How might ERRg control metabolism, VEGF induction, and
vasculature remodeling in ERRGOmice in absence of enhanced
PGC-1a signaling? We focused on the alternative aerobic
master-regulator—AMPK—because of its known role in meta-
bolic (Fujii et al., 2007, 2008) and vascular adaptation (Zwetsloot
et al., 2008). While AMPK is normally induced by exercise or
hypoxia, surprisingly, we found it to be constitutively activated
in ERRGO muscle (Figures 6B and 6C). The AMPK activation
was further validated by measuring phospho-ACC levels (an
AMPK target and a biomarker of AMPK activity), which we found
to be higher in the transgenic compared to the WT muscles (Fig-
ure S5B). ATP consumption is critical to AMPK activation, as
AMP stimulates and ATP inhibits the enzyme (Xiao et al.,
2007). Indeed, we found that ATP levels were lower in ERRg-
overexpressing compared to control C2C12 muscle cells,
providing a biochemical basis for the observed AMPK activation
(Figure S5C). (Note that we use cultured muscle cells for
measuring ATP levels because ERRg overexpression promotes
both angiogenic gene expression as well as oxidative respiration
in a fashion similar to transgenic muscle.) Interestingly, in WT
mice, we found that AMPK is more active in predominantly
oxidative slow-twitch compared to predominantly glycolytic
fast-twitch muscle in resting state (Figures 6B and 6C). Indeed,
a synthetic activator, AICAR, at a dose (500 mg/kg/day) previ-
ously shown to stimulate AMPK in anaerobic muscle and
improve aerobic performance (Narkar et al., 2008), was able to
direct aspects of skeletal muscle transformation in a fashion
similar to ERRg (Figure 6D). These observations suggest a
convergence between ERRg and AMPKpathways that comprise
an exercise-independent mechanism to direct intrinsic vascular-
ization and oxidative metabolism in type I muscle, as depicted in
Figure 6E.
DISCUSSION
Oxidative slow-twitch muscle beds are highly vascularized,
pointing to an underlying regulatory network that integrates
blood flow to myocellular metabolism. A transcriptional pathway
specifying intrinsic differences between type I and II muscles has
not previously been identified. Discovery of the components of
this network has implications in treating cardiovascular diseases
commonly linked to peripheral vascular degeneration due to
ischemia. Here, we show that in the skeletal muscle, ERRg is
exclusively expressed in highly vascularized aerobic muscles.
Transgenic overexpression of ERRg is sufficient to enable anaer-
obic muscles to acquire enhanced oxidative capacity and dense
vasculature. The observedmorphological remodeling is linked to
induction by ERRg of genes controlling oxidative phosphoryla-
tion, fatty acid oxidation, and oxidative slow-twitch myofibers
as well as a parallel induction of proangiogenic genes involved
in paracrine regulation of vasculature. At a functional level, these
genetic changes impart high oxygen-consuming and exercising
capacity as well as resistance to diet-induced obesity to the
ERRGO mice. Surprisingly, these effects are independent of
PGC-1a and instead are associated with ERRg-directed AMPK
activation in themuscle. Therefore, ERRg regulates blood supply
AB C
D E
Figure 6. PGC-1a-Independent Regulation by
ERRg
(A) Relative expression of PGC-1a, Erra, and Errb genes in
WT and transgenic muscle (n = 6). Data are presented as
mean ± SD. * represents significant difference between
WT and transgenic mice (p < 0.05, unpaired Student’s
t test).
(B) Phospho-AMPK (upper panel) and total-AMPK (lower
panel) in soleus (SOL) and quadriceps (QUAD) of WT and
transgenic mice (n = 3).
(C) Quantification of AMPK activation (phospho- to total-
AMPK ratio) by densitometric analysis, presented as fold
of WT soleus (n = 3). Data is presented as mean ± SD.
(D) Representative images of SDH staining of muscle
cryosections from vehicle and AICAR (500 mg/kg/day for
4 weeks) treated mice. Similar results were obtained
from n = 3 mice.
(E) Synchronization of metabolism and vasculature by
ERRg in aerobic muscle. See Figure S5.
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ERRg Increases Muscle Vascularizationto aerobic muscles and, perhaps, is a transcriptional gauge of
myocellular supply and demand.
Although skeletal muscle adapts to exercise by increasing
oxidative metabolism and vascular supply via induction of tran-
scriptional regulators such as PGC-1a (Arany et al., 2008; Baar
et al., 2002; Huss et al., 2002; Pilegaard et al., 2003; Russell
et al., 2003, 2005), how type I fibers achieve intrinsic vasculariza-
tion even in the absence of exercise is poorly understood. We
show here that one such molecular pathway involves nuclear
receptor ERRg—highly expressed in oxidative slow-twitch
muscles. Targeted expression of ERRg to quadriceps and white
gastrocnemius, where the receptor is typically not expressed,
morphologically endows these muscles with dense vascular
supply and numerous slow-twitch characteristics. Recently, it
was reported that muscle-specific overexpression of a constitu-
tively active ERRg (VP16-ERRg) imparts an oxidative metabolic
phenotype to the skeletal muscle (Rangwala et al., 2010).
However, the effect of VP16-ERRg on muscle vascularization
was not evaluated in these mice.
Genome-wide expression analysis revealed that ERRg acts by
coordinately inducing gene networks promoting mitochondrial
biogenesis, oxidative transformation, and angiogenesis. The
ERRg program includes mobilization and oxidation of fat (e.g.,Cell Metabolism 13,Acadl,Acadm,Cpt1b,Cpt2, Lpl), electron trans-
port (e.g., Atp5h, Cox6a2, Ndufab1, Ndufb2m,
Ndufv1, Sdhb), mitochondrial biogenesis (e.g.,
Mfn1), and formation of energy-efficient, slow-
contractile muscle (e.g., Tnnc1, Tnni1, Tnnt1).
The observed changes constituting transforma-
tion of the contractile apparatus to a slow
phenotype and increase in oxidative metabolic
genes reflected in profound increase in mito-
chondrial (SDH) staining represents a fiber
type switch. Notably, ERRg also induces key
transcriptional inducers of oxidative metabolism
including Esrrb, Ppara, Ppard, and Ppargc1b
(Table S4) (Lin et al., 2002; Minnich et al.,
2001; Muoio et al., 2002; Wang et al., 2004).
Therefore, it is likely that ERRg is a criticalupstream genetic switch that may determine metabolic fate by
presiding over the expression of multiple aerobic regulators.
We hypothesize that the vascular program triggered by myo-
cellular ERRg activates a transcriptional program that directs
secretion of paracrine signals into skeletal muscle microenviron-
ment to induce angiogenesis. This model is strongly supported
by our observation that conditioned media from ERRg overex-
pressing C2C12 myotubules is able to induce endothelial cell
tube formation in culture. Indeed, ERRg transcriptionally induced
all isoforms of angiokine Vegfa in C2C12 myotubes, resulting in
increased Vegfa secretion into the media. Vegfa is a key regu-
lator of angiogenesis critical for guiding endothelial cells to their
targets (Grunewald et al., 2006; Springer et al., 1998). Further-
more, ERRg stimulates the Vegfa promoter containing putative
ERR binding sites that is known to transcribe all Vegfa isoforms
(Arany et al., 2008). Vegfa mRNA and protein expression are also
induced in ERRGO muscle. These findings collectively raise the
possibility of direct transcriptional activation of angiogenic genes
by ERRg. However, it is important to note that the angiogenic
effects of ERRg cannot be solely attributed to Vegfa induction
and secretion. For example, ERRg additionally activates the
expression of Fgf1 and Cxcl12, known to regulate endothelial
cell proliferation and migration (Forough et al., 2006; Gupta283–293, March 2, 2011 ª2011 Elsevier Inc. 289
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2007), along with Efnb2, proposed to recruit mural cells that are
required for vessel maturation (Foo et al., 2006). Additionally, up-
regulated factors such asNotch4 as well as Sox17 are transcrip-
tional regulators of vasculogenesis (Hainaud et al., 2006; Leong
et al., 2002; Matsui et al., 2006). In this aspect, ERRg seems to
serve a function similar to HIF1a, a known master regulator of
angiogenesis during hypoxia (Pajusola et al., 2005). Interestingly,
it was recently demonstrated that ERRsmight physically interact
with HIF1a in regulating its transcriptional activity (Ao et al.,
2008). Whether such a mechanism is relevant to our model
remains to be determined. Along these lines, HIF1a mRNA
levels—amarker for chronic hypoxia—did not change in ERRGO
compared to WT muscles (data not shown), indicating an
absence of hypoxia or its involvement in the vascular effects of
ERRg (Hoppeler and Vogt, 2001a, 2001b). Furthermore, HIF1a
is known to negatively regulate oxidative metabolism (Mason
et al., 2004, 2007) and is therefore unlikely to contribute to
ERRg-mediated remodeling of skeletal muscles.
ERRGO mice exhibited increased oxygen consumption,
decreased RER, high running endurance, and resistance to
diet-induced weight gain. These changes are physiological hall-
marks of increased aerobic capacity in mice and are a direct
consequence of engineering highly oxidative and vascularized
muscle by ERRg. While similar remodeling of skeletal muscle
and aerobic physiology are triggered by exercise, our data prove
that generation of a fully functional ‘‘endurance vasculature’’ is
not exercise dependent (Bloor, 2005; Egginton, 2009; Gavin
et al., 2007; Gustafsson and Kraus, 2001; Jensen et al., 2004;
Waters et al., 2004). Reciprocally, the extent to which ERRg
signaling in skeletal muscle contributes to exercise adaptation
remains to be determined.
A surprising finding of our study was lack of change in the
expression of PGC-1a, a known and inducible regulator of
aerobic muscles, in the ERRg-transformed muscle. One alterna-
tive possibility is posttranslational activation of PGC-1a without
change in its expression (Ja¨ger et al., 2007; Puigserver et al.,
2001; Rodgers et al., 2005). Deacetylation of PGC-1a is critical
for its activation in the skeletal muscle (Canto´ et al., 2010; Ger-
hart-Hines et al., 2007; Lagouge et al., 2006). However, ERRg
overexpression did not lead to deacetylation of PGC-1a, which
remained comparably acetylated in both the WT and ERRGO
muscles. The lack of posttranslational activation of the cofactor
in ERRGO mice is further underscored by a previous report that
nongenomic activation of PGC-1a typically leads to its transcrip-
tional induction, whichwe did not observe in these studies (Ja¨ger
et al., 2007). Along the same lines, it was recently shown that
both PGC-1a and b are dispensable for fiber type specification
in the skeletal muscle (Zechner et al., 2010). In contrast, we
find that an alternative aerobic master regulator, AMPK, is
activated by ERRg in the skeletal muscles. AMPK is typically
activated by exercise (Fujii et al., 2000; Winder and Hardie,
1996; Wojtaszewski et al., 2000) and is essential for exercise-
mediated switch to aerobic myofibers in the skeletal muscle
(Ro¨ckl et al., 2007). Indeed, transgenic activation of AMPK in
the skeletal muscle increases the proportions of oxidative myo-
fibers in absence of any exercise (Ro¨ckl et al., 2007). Similarly,
we found that chemical activation of AMPK by AICAR triggers
aerobic transformation of type II muscle. However, AMPK alone290 Cell Metabolism 13, 283–293, March 2, 2011 ª2011 Elsevier Inc.is unlikely to mediate all the ERRg effects, and contribution by
additional metabolic regulators (e.g., calcineurin, SIRT1, etc.) in
ERRGO mice cannot be ruled out. This is possible because,
unlike ERRg, AMPK activation apparently does not lead to
a complete transformation to a type I phenotype, but to more
intermediate type IIa and IIx oxidative myofibers (Ro¨ckl et al.,
2007). In this context, it is peculiar that we found AMPK to be
naturally and selectively active in soleus (predominantly type I
myofibers) compared to quadriceps (predominantly type II myo-
fibers). Previous studies have suggested AMPK activity to be
similar between soleus and EDL (also predominantly made up
of type II myofibers) (Dzamko et al., 2008; Jensen et al., 2007;
Jørgensen et al., 2004). Speculatively, this discrepancy may
have technical attributes or may even be linked to possible
differences in recruitment of EDL and quadriceps for postural
activity that might affect basal AMPK activation. Nevertheless,
our results demonstrate that in the context of overexpression,
ERRg is sufficient to initiate both metabolic and vascular path-
ways to drive aerobic remodeling of sedentary muscle indepen-
dently of PGC-1a by recruiting alternative regulators such as
AMPK (see Figure 6E).
Multiple diseases, including obesity and diabetes, are
commonly linked to deregulation of both oxidative metabolism
and vascularity. A shared therapeutic approach to these condi-
tions includes exercise that activates a plethora of transcriptional
pathways to increase aerobic metabolism and vascularization to
ultimately enhance performance (Bloor, 2005; Egginton, 2009;
Gavin et al., 2007; Gustafsson and Kraus, 2001; Jensen et al.,
2004; Waters et al., 2004). Our findings present a possibility of
therapeutically exploiting ERRg to simultaneously regulate
oxidative capacity and vascularity. High expression levels of
this receptor in tissues most prone to metabolic and vascular
diseases (e.g., heart, skeletal muscle, brain, and kidney) further
potentiates its value as a potential pharmacologic target (Ariazi
et al., 2002; Cheung et al., 2005; Gao et al., 2006; Gigue`re,
2008; Heard et al., 2000; Hong et al., 1999). In summary, our
studies show that ERRg controls mitochondrial function and
metabolism together with angiogenesis that anatomically
synchronizes vascular arborization to oxidative metabolism.
EXPERIMENTAL PROCEDURES
Animals
Mouse ERRg cDNA was placed downstream of the human a-skeletal actin
promoter and upstream of the SV40 intron/poly (A) sequence. The purified
transgene was injected into C57BL/6J 3 CBA F1 zygotes. Two transgenic
founders (TG 425 and 421) were obtained that were backcrossed for five
generations with C57BL/6J. All experiments used age-matched (2–3 months)
and sex-matched (male) transgenic andWT littermates. Mice were maintained
on a normal chow diet. ERRg +/ mice and tissue b-galactosidase staining
have been described previously (Alaynick et al., 2007).
Drug Treatment
Male C57BL/6J mice (8 weeks old) were intraperitoneally injected with vehicle
or AICAR (500 mg/kg/day), as previously described (Narkar et al., 2008).
Gene and Protein Expression Analysis
RNA was extracted using TRIzol extraction method from quadriceps or soleus
isolated from WT and transgenic mice. Additionally, protein lysates were
prepared from quadriceps and analyzed by western blotting with myoglobin
(Dako), CYCS (Santa Cruz), UCP3 (Affinity Bioreagents), phospho-AMPKa
Cell Metabolism
ERRg Increases Muscle Vascularization(Cell Signaling, cat. no. #2535), and total-AMPKa (Cell Signaling, cat. no.
#2532) antibodies. Note that the AMPK antibodies detect both the a1 and 2
catalytic subunits of AMPK (Narkar et al., 2008).
Microarray Analysis
Global gene expression analysis was performed in quadriceps from WT and
transgenic mice, as previously described (Narkar et al., 2008).
Muscle Staining and Immunohistochemistry
SDH, PECAM/CD31, and alkaline phosphates staining are described in the
Supplemental Experimental Procedures.
Fluorescence Microangiography
Blood vessel mapping was performed as previously described (Johnson et al.,
2004; Springer et al., 2000). Briefly, a red fluorescent microsphere (0.1 mM)
suspension was intraventricularly perfused (10 ml, 1 ml/min), followed by
euthanasia and tissue collection. Longitudinal cryosections (10 mM) of frozen
gastrocnemius were processed and subjected to confocal microscopy to
image skeletal muscle vasculature.
Cell Culture, In Vitro Angiogenesis, and Vegfa ELISA
See Supplemental Experimental Procedures.
Oxymetery and Treadmill Assays
Oxygen consumption, RER, and ambulatory activity were measured in
3-month-old WT and transgenic male mice (n = 6–7/group) of comparable
weight usingComprehensive Lab AnimalMonitoring System to obtain oxymet-
ric measurements (Columbus Instruments). These mice were first acclimated
in the monitoring system for 1 day, followed by data collection for 24 hr to
include a 12 hr light and dark cycle. For each animal, the average of all the
data points within the light or dark phase was used as a representative value
of the respective cycle. Diurnal differences between the light and dark cycles
were detectable in all animals, validating the method of data collection.
Endurance was determined in WT and transgenic mice (n = 6/group), as
previously described (Narkar et al., 2008). Treadmill protocol is described in
Supplemental Experimental Procedures.
Data Analysis
Data was analyzed using either one way ANOVA with an appropriate post hoc
test or unpaired Student’s t test, as indicated.
ACCESSION NUMBERS
The global gene expression data has been deposited in the NCBI Gene
Expression Omnibus under the GEO series accession number GSE22086.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
five figures, and four tables and can be found with this article online at
doi:10.1016/j.cmet.2011.01.019.
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